{"name": "RepRegen",
 "permalink": "repregen",
 "crunchbase_url": "http://www.crunchbase.com/company/repregen",
 "homepage_url": "http://www.repregen.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@repregen.com",
 "phone_number": "508-359-4005",
 "description": "",
 "created_at": "Wed Nov 17 02:28:33 UTC 2010",
 "updated_at": "Wed Nov 17 02:28:32 UTC 2010",
 "overview": "\u003Cp\u003EA spin-out from Imperial Innovations plc and headquartered within the Imperial College Incubator, RepRegen is poised to commercialize the initial product of its hard tissue repair and regeneration platform: StronBone\u00e2\u201e\u00a2 Bone Graft Substitute. The Company\u00e2\u20ac\u2122s hard tissue platform is based on \u0026#8216;smart\u0026#8217; bioceramics designed to be used, initially, by orthopedic product manufacturers and surgeons. A major RepRegen materials science innovation is the use of Strontium, boosting the performance of the bioceramics.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       130],
      "assets/images/resized/0011/0533/110533v1-max-150x150.jpg"],
     [[250,
       217],
      "assets/images/resized/0011/0533/110533v1-max-250x250.jpg"],
     [[262,
       228],
      "assets/images/resized/0011/0533/110533v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Ian",
      "last_name": "Brown",
      "permalink": "ian-brown-2",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$1.6M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2010/11/repregen-ltd-london-uk-based-medical.html",
    "source_description": "RepRegen Ltd, a London, UK-based medical device company that develops products to repair and restore tissue, has raised \u00c2\u00a31.03m (approximately $1.6m) in funding.",
    "raised_amount": 1600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 11,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Imperial Innovations",
         "permalink": "imperial-innovations",
         "image":
          {"available_sizes":
            [[[65,
               150],
              "assets/images/resized/0004/6361/46361v1-max-150x150.jpg"],
             [[108,
               250],
              "assets/images/resized/0004/6361/46361v1-max-250x250.jpg"],
             [[193,
               445],
              "assets/images/resized/0004/6361/46361v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Longbow Capital",
         "permalink": "longbow-capital",
         "image":
          {"available_sizes":
            [[[150,
               29],
              "assets/images/resized/0004/5590/45590v1-max-150x150.png"],
             [[204,
               40],
              "assets/images/resized/0004/5590/45590v1-max-250x250.png"],
             [[204,
               40],
              "assets/images/resized/0004/5590/45590v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}